TY - JOUR T1 - Update on the Use of Steroids in Rheumatoid Arthritis JO - Reumatología Clínica (English Edition) T2 - AU - García-Magallón,Blanca AU - Silva-Fernández,Lucía AU - Andreu-Sánchez,José Luis SN - 21735743 M3 - 10.1016/j.reumae.2013.01.015 DO - 10.1016/j.reumae.2013.01.015 UR - https://reumatologiaclinica.org/en-update-on-use-steroids-in-articulo-S2173574313000907 AB - Corticosteroids are a mainstay in the therapy of rheumatoid arthritis (RA). In recent years, a number of high-quality controlled clinical trials have shown their effect as a disease-modifying anti-rheumatic drug (DMARD) and a favorable safety profile in recent-onset RA. Despite this, they are more frequently used as bridge therapy while other DMARDs initiate their action than as true disease-modifying agents. Low-dose corticosteroid use during the first two years of disease slows radiologic damage and reduces the need of biologic therapy aimed at reaching a state of clinical remission in recent-onset RA. Thus, their systematic use in this clinical scenario should be considered. ER -